Eli Lilly Sues Six Firms Over Illicit Sales Of Experimental Retatrutide
29m
Developing
1
On Wednesday, August 12, 2026, Eli Lilly sued six companies in U.S. courts, alleging they illegally sold experimental obesity drug retatrutide that is not FDA-approved. CBS News
